Annotation Detail

Information
Associated Genes
NRG1
Associated Variants
NRG1 EXPRESSION
NRG1 EXPRESSION
Associated Disease
lung non-small cell carcinoma
Source Database
CIViC Evidence
Description
In-vivo studies of residual NSCLC tumors (xenografts of 5 cell lines) after chemotherapy found increased EGFR-family signaling and NRG1 expression. NRG1 inhibition (YW538.24.71 antibody) led to decreased tumor growth and enhanced magnitude and response to chemotherapy.
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/779
Gene URL
https://civic.genome.wustl.edu/links/genes/2593
Variant URL
https://civic.genome.wustl.edu/links/variants/314
Rating
3
Evidence Type
Predictive
Disease
Lung Non-small Cell Carcinoma
Evidence Direction
Supports
Drug
Cisplatin,Gemcitabine,Carboplatin,Paclitaxel
Evidence Level
D
Clinical Significance
Sensitivity/Response
Pubmed
23390248
Drugs
Drug NameSensitivitySupported
CarboplatinSensitivitytrue
CisplatinSensitivitytrue
GemcitabineSensitivitytrue
PaclitaxelSensitivitytrue